What's new in PMS?

Article

PMS has been a legitimate diagnosis for several decades, but there are no FDA-approved therapies for it. Off-label use of medications that are FDA-approved for PMDD is common in clinical practice. For patients taking daily SSRIs for anxiety or mood symptoms, premenstrual dose adjustment offers a novel management strategy.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Subscribe Now!
Recent Videos
Unveiling gender disparities in medicine | Image Credit: findcare.ahn.org.
John Stanley, MD
Related Content
Guiding ob-gyns back to evidence-based care | Image Credit: © Iryna - stock.adobe.com.

Guiding ob-gyns back to evidence-based care

Brian K. Iriye, MD;James D. Keller, MD, MHSA
August 24th 2025
Article

Read More

Pap Talk presented by Contemporary OB/GYN

S2E2: Overcoming Racism and Unconscious Bias in OB/GYN

Contemporary OB/GYN Staff
August 24th 2025
Podcast

Listen

Anger hurts your team’s performance and health, and yours too | Image Credit: © tuaindeed - © tuaindeed - stock.adobe.com.

Anger hurts your team’s performance and health, and yours too

James D. Keller, MD, MHSA;Brian K. Iriye, MD
August 24th 2025
Article

Read More

Do you know you are being scored?

Do you know you are being scored?

James D. Keller, MD, MHSA;Brian K. Iriye, MD
August 24th 2025
Article

Read More

Study finds high rates of harassment in OB-GYN | Image Credit: © Vitalii Vodolazskyi - © Vitalii Vodolazskyi - stock.adobe.com.

Study finds high rates of harassment in OB-GYN

Celeste Krewson, Assistant Editor
August 24th 2025
Article

Read More

Survey: State abortion access impacted OB/GYN residency applications

Survey: State abortion access impacted OB/GYN residency applications

Kevin Kunzmann
August 24th 2025
Article

Read More

© 2025 MJH Life Sciences

All rights reserved.